🔗 Share this article

The top legal official in Texas Paxton is suing the producers of acetaminophen, asserting the companies hid potential risks that the drug created to children's brain development.

This legal action follows a month after President Donald Trump promoted an unverified association between using Tylenol - also known as paracetamol - while pregnant and autism in young ones.

The attorney general is suing J&J, which formerly manufactured the medication, the sole analgesic approved for expectant mothers, and the current manufacturer, which currently produces it.

In a declaration, he said they "deceived the public by making money from discomfort and promoting medication ignoring the dangers."

The manufacturer states there is insufficient reliable data connecting acetaminophen to autism spectrum disorder.

"These companies lied for decades, deliberately risking countless individuals to line their pockets," the attorney general, from the Republican party, stated.

Kenvue said in a statement that it was "seriously troubled by the perpetuation of misinformation on the security of paracetamol and the potential impact that could have on the health of American women and children."

On its online platform, the company also mentioned it had "consistently assessed the pertinent research and there is lacking reliable evidence that shows a established connection between using paracetamol and autism spectrum disorder."

Groups representing physicians and healthcare providers concur.

The American College of Obstetricians and Gynecologists has declared acetaminophen - the key substance in Tylenol - is among limited choices for women during pregnancy to manage discomfort and fever, which can present serious health risks if ignored.

"In over twenty years of investigation on the consumption of paracetamol in gestation, no reliable research has successfully concluded that the use of paracetamol in any stage of gestation causes brain development issues in young ones," the organization commented.

The lawsuit references recent announcements from the former administration in asserting the drug is potentially dangerous.

Last month, Trump generated worry from public health officials when he told pregnant women to "struggle intensely" not to use acetaminophen when unwell.

The FDA then issued a notice that doctors should contemplate reducing the consumption of acetaminophen, while also stating that "a proven link" between the medication and autism in minors has remains unverified.

The Health Department head Kennedy, who supervises the Food and Drug Administration, had promised in spring to conduct "a massive testing and research effort" that would determine the source of autism in a short period.

But experts advised that finding a single cause of autism - considered by experts to be the outcome of a intricate combination of inherited and environmental factors - would prove challenging.

Autism spectrum disorder is a category of permanent neurological difference and disability that influences how people encounter and relate to the surroundings, and is recognized using medical professional evaluations.

In his lawsuit, the attorney general - aligned with the former president who is running for federal office - asserts Kenvue and J&J "willfully ignored and attempted to silence the research" around paracetamol and autism.

The lawsuit attempts to require the firms "remove any marketing or advertising" that claims acetaminophen is safe for expectant mothers.

The court case parallels the grievances of a assembly of guardians of children with autism and ADHD who filed suit against the manufacturers of acetaminophen in 2022.

The court dismissed the lawsuit, saying studies from the family's specialists was inconclusive.